➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
McKesson
Merck
Johnson and Johnson
Boehringer Ingelheim

Last Updated: August 13, 2020

DrugPatentWatch Database Preview

Claims for Patent: 5,236,829

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,236,829
Title: Method of producing monokine induced by gamma interferon
Abstract:Monokines are provided which are produced by monocytic cells of mammals which have been stimulated with interferon-.gamma.. cDNA sequences encoding the monokines are also disclosed. Methods of producing the mammalian monokines are taught. The monokines are implicated in immunological and inflammatory processes, as are other members of the platelet factor 4 family of cytokines.
Inventor(s): Farber; Joshua (Baltimore, MD)
Assignee: The Johns Hopkins University (Baltimore, MD)
Application Number:07/624,742
Patent Claims:1. An intron-free DNA molecule encoding a mammalian MIG protein which has the nucleotide sequence shown in SEQ ID NO: 2 or 4.

2. The intron-free DNA molecule of claim 1 which encodes a protein having the amino acid sequence shown in SEQ ID NO: 1 or 3.

3. The intron-free DNA molecule of claim 1 which is derived from a mouse.

4. The intron-free DNA molecule of claim 2 which is derived from a mouse.

5. The intron-free DNA molecule of claim 1 which is derived from a human.

6. The intron-free DNA molecule of claim 2 which is derived from a human.

7. A host cell which comprises a DNA molecule of claim 1 which has the nucleotide sequence shown in SEQ ID NO: 2 or 4.

8. A host cell which comprises a DNA molecule of claim 2 which encodes a protein having the amino acid sequence shown in SEQ ID NO: 1 or 3.

9. A method of producing a mammalian MIG protein, comprising the steps of:

providing a host cell comprising the DNA molecule of claim 1;

culturing the host cell in a nutrient medium so that the mammalian MIG protein is secreted into the medium; and

harvesting the mammalian MIG protein from the nutrient medium.

10. The method of claim 9 in which the DNA molecule encodes a protein having the amino acid sequence shown in SEQ ID NO: 1 or 3.

11. The method of claim 9 wherein the host cell comprises an intron-free DNA molecule which has the nucleotide sequence shown in SEQ ID NO: 2 or 4.

12. The method of claim 9 wherein the host cell comprises an intron-free DNA molecule which encodes a protein having the amino acid sequence shown in SEQ ID NO: 1 or 3.

Details for Patent 5,236,829

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial The Johns Hopkins University (Baltimore, MD) 2039-02-26 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial The Johns Hopkins University (Baltimore, MD) 2039-02-26 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Start Trial The Johns Hopkins University (Baltimore, MD) 2039-02-26 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
McKesson
Dow
Express Scripts
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.